CAV1 and neoplasm: To this end, recipient WT mice transferred with OVA257–264-loaded WT or CAV1−/− DCs were challenged with ovalbumin-expressing B16 (B16-OVA) melanoma cells, and tumor growth was monitored every 2–3 days (Figure 5A).